ArticleBMC plant biology2026
Two taxonomically similar plant species are projected to become the key alternative wild resources to Ardisia crenata Sims.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe overharvesting and habitat degradation of Ardisia crenata Sims (ZSG) urgently necessitate sustainable alternatives. Ardisia crenata subsp. crenata (HLS) and Ardisia crispa (Thunb.) A. DC (BLJ) emerge as promising candidates. We comprehensively compared the three plants in terms of morphological characteristics, biomass, bergenin content, metabolite profiles, and therapeutic efficacy. The results showed that the three plants shared 96.5% similarity in their metabolites and key active ingredients. They also exhibited comparable morphological characteristics, biomass, therapeutic effects, and similar serum metabolite profiles in rats with acute pharyngitis. Our findings indicate that HLS and BLJ may be considered as potential alternative medicinal resources. This approach offers potential benefits, including alleviating resource pressure and providing medicinal materials with comparable biomass and efficacy to meet clinical and pharmaceutical needs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.